Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TomaGold Borehole EM Survey Confirms Berrigan Deep Zone (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Cingulate Inc CING

Alternate Symbol(s):  CINGW

Healthcare Biotechnology
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company’s lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for... see more

Current News (NDAQ:CING)

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25

Newsfile November 18, 2025

Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire November 13, 2025

Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

GlobeNewswire November 10, 2025

Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control

GlobeNewswire October 28, 2025

Cingulate's Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

GlobeNewswire October 23, 2025

FDA Accepts Cingulate's New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date

GlobeNewswire October 14, 2025

Cingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment

GlobeNewswire September 17, 2025

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25

Newsfile August 21, 2025

Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights

GlobeNewswire August 19, 2025
View More News ››

Opinion & Analysis (NDAQ:CING)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CING)

CING.....Buyer beware IMHO

dump fest about to start  Last at $10.15
Iseneschal - August 26, 2024

CING....Aug 23 vote to release these warrants FYI

sec.gov/Archives/edgar/data/1862150/000149315224028947/form424b3.htm
Iseneschal - August 26, 2024

BUY BUY BUY BUY BUY

It is not too late still regret from tuesday when it was at 2$ 
Nibinator - August 16, 2024

Cingulate Inc. (NASDAQ:CING): A Promising Biopharmaceutical

http://beyondspx.com/2024/08/01/cingulate-inc-nasdaqcing-a-promising-biopharmaceutical-company-advancing-novel-adhd-treatments/
MikeTester - August 2, 2024

CING....P.O announced

Syonarra
Iseneschal - February 2, 2024

Fingers Crossed. He Sounds Good

https://channelchek.com/news-channel/Cingulate__CING__NobleCon18_Presentation_Replay
SmallCapPaul - May 15, 2022
View more Bullboard ››

Almonty Industries Inc.

Almonty Industries Inc.

Almonty Industries Inc. engages in mining, processing, and shipping of tungsten concentrate. The company explores for tin and ...
View More »

Podcasts